SCREENING FOR THALASSEMIA CARRIERS USING MOLECULAR ABSORPTION SPECTROSCOPY
Main Article Content
Abstract
Background: The first step is to test the turbidity of the reagents in the OF test by molecular adsorption spectroscopy. The research aims to quantify the qualitative test from which it is possible to provide the indicators to evaluate the accuracy of the test such as the sensitivity and specificity of the measurement method. Objective: To evaluate the value of screening test for carriers of congenital hemolytic disease using molecular absorption spectroscopy. Materials and methods: 80 samples of venous blood from normal people and people carrying thalassemia gene, performed at the Department of Biochemistry - and the laboratory of Physics - Biophysics of the University of Medicine and Pharmacy. Results: The mean age of study subjects was 30±4.5. The average optical absorbance at the 416 nm peak of the negative sample is 3.45 ± 0.31, of the positive sample is 2.1 ± 0.78, the difference is statistically significant. OF test showed sensitivity and specificity of 85.2% and 80.0%, respectively. Area under the ROC curve (AUC) of Abs416=0.9; The AUC of the OF test was 0.725 (p<0.05). Conclusion: The absorption peak at 416 nm gives the best prognostic value with the area under the curve ROC = 0.90 while that of the OF test is only 0.725 when compared with the standard curve. The difference is statistically significant.
Article Details
Keywords
OF test, optical absorbance, thalassemia, molecular absorption spectrum
References
2. Trực, D.B., Tình hình bệnh thalassemia và bệnh hemoglobin ở người Mường tại Hòa Bình. Tạp chí Y Học Việt Nam, 2010. 2, 47-51.
3. Vân, V.T.B., Nghiên cứu tỷ lệ mang gen beta thalassemia và mối liên hệ với một số chỉ số hồng cầu ngoại vi ở trẻ em dân tộc Tày và Dao huyện Định Hoá tỉnh Thái Nguyên. Tạp chí Y Học Việt Nam. 2010. 2, 51-55.
4. Ismail, M. and N.G. Patel, Effectiveness of naked eye single tube osmotic fragility test for screening of β-thalassemia trait from north Maharashtra region. India. 2017. 3(5), 6, doi: https://doi.org/10.18203/2394-6040.ijcmph20161394.
5. O'Riordan, S., et al., Large scale screening for haemoglobin disorders in southern Vietnam:
implications for avoidance and management. Br J Haematol. 2010. 150(3), 359-64, doi:
10.1111/j.1365-2141.2010.08237.
6. Old J, Harteveld CL, Traeger-Synodinos J, et al. Prevention of Thalassaemias and Other
Haemoglobin Disorders: Volume 2: Laboratory Protocols [Internet]. 2nd edition. Nicosia (Cyprus): Thalassaemia International Federation; 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK190576.
7. Hải, L.X., Nghiên cứu giá trị xét nghiệm sàng lọc thalassemia bằng nước muối 1 nồng độ trong nhóm bệnh nhân và người khám sức khỏe tại Viện Huyết học Truyền máu Trung Ương. Tạp chí Y học Việt Nam. 2015. 448, 36-44.
8. Sangkitporn, S., et al., Validation of osmotic fragility test and dichlorophenol indophenol precipitation test for screening of thalassemia and Hb E. Southeast Asian J Trop Med Public Health. 2005. 36(6), 1538-42, PMID: 16610659.
9. Khera, R., et al., HPLC in characterization of hemoglobin profile in thalassemia syndromes and hemoglobinopathies: a clinico haematological correlation. Indian J Hematol Blood Transfus. 2015. 31(1), 110-5, doi: 10.1007/s12288-014-0409-x.
10. Khosa, S.M., et al., Comparative analysis of cellulose acetate hemoglobin electrophoresis and high-performance liquid chromatography for quantitative determination of hemoglobin A2. Blood Res. 2015. 50(1), 46-50, doi: 10.5045/br.2015.50.1.46.